Allergy pill may shield cancer patients from dangerous treatment reactions

This study tested if adding montelukast (Singulair), a drug used for asthma and allergies, to standard pre-treatment medications could reduce severe infusion reactions in patients receiving monoclonal antibody treatments for blood cancers. The trial involved 40 adults with blood disorders who were starting treatment with one of six specific antibody drugs. Researchers measured whether the extra medication led to fewer and less severe reactions, shorter infusion times, and fewer treatment interruptions.